Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EYENOVIA, INC.

(EYEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société EYENOVIA, INC.
09/15EYENOVIA : Material Definitive Agreement (Form 8-K)
PU
09/15EYENOVIA, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
08/12EYENOVIA : Management's Discussion and Analysis of Financial Condition and Results of Oper..
AQ
08/11EYENOVIA : Announced positive topline data from its Phase 3 VISION-1 study evaluating Micr..
PU
08/11EYENOVIA, INC. : Results of Operations and Financial Condition, Other Events, Financial St..
AQ
08/11Eyenovia Reports Second Quarter 2021 Financial Results
GL
08/04Eyenovia to Report Second Quarter 2021 Results on Wednesday, August 11
GL
07/19EYENOVIA : to Participate in a Presbyopia Panel Discussion at Eyecelerator 2021
BU
07/07Eyenovia to Participate in Two Upcoming Investor Conferences
GL
06/21EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/16EYENOVIA, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/15EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/15EYENOVIA : highlights Recent Progress in Three Phase 3 Programs, NDA Review Progress and L..
PU
06/15Eyenovia highlights Recent Progress in Three Phase 3 Programs, NDA Review Progress and ..
GL
05/25Eyenovia Announces Positive Topline Results from VISION-1 Phase 3 Clinical Study of Mic..
GL
05/25EYENOVIA : Announces Positive Topline Results from VISION-1 Phase 3 Clinical Study of Micr..
PU
05/25EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05/14EYENOVIA, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhi..
AQ
05/14EYENOVIA : Management's Discussion and Analysis of Financial Condition and Results of Oper..
AQ
05/14EYENOVIA : Completed patient enrollment in Phase 3 VISION-1 study evaluating MicroLine for..
PU
05/12EYENOVIA, INC. : Results of Operations and Financial Condition, Financial Statements and E..
AQ
05/12Eyenovia Reports First Quarter 2021 Financial Results
GL
05/12EYENOVIA : Announces New $25 Million Credit Facility with Silicon Valley Bank (Form 8-K)
PU
05/10EYENOVIA, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financia..
AQ
05/10Eyenovia Announces New $25 Million Credit Facility with Silicon Valley Bank
GL
05/05EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05/05Eyenovia to Report First Quarter 2021 Results on Wednesday, May 12
GL
04/01EYENOVIA, INC. : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
04/01EYENOVIA : Announces Appointment of Renowned Ophthalmologist and Scientific Leader Dr. Jul..
BU
03/30EYENOVIA : Management's Discussion and Analysis of Financial Condition and Results of Oper..
AQ
03/25EYENOVIA, INC. : Results of Operations and Financial Condition, Financial Statements and E..
AQ
03/25Eyenovia Reports Fourth Quarter and Full Year 2020 Financial Results
GL
03/24EYENOVIA : and EVERSANA Announce Partnership to Support the Potential Launch and Commercia..
AQ
03/23EYENOVIA : and EVERSANA Announce Partnership to Support the Potential Launch and Commercia..
BU
03/18EYENOVIA : Announces Publication of MIST Pivotal Studies Demonstrating the Efficacy and Sa..
AQ
03/18EYENOVIA : to Report Fourth Quarter and Full Year 2020 Results on Thursday, March 25
AQ
03/17EYENOVIA : Announces Publication of MIST Pivotal Studies Demonstrating the Efficacy and Sa..
BU
03/15EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
03/10EYENOVIA : to Participate in the 33rd Annual Roth Conference
AQ
03/02EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
03/02EYENOVIA : Announces FDA Acceptance of the MydCombi NDA
BU
02/16EYENOVIA : to Host Key Opinion Leader Webinar on Presbyopia
AQ
02/03EYENOVIA, INC. : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
01/27EYENOVIA : to Present at the Ophthalmology Innovation Summit Presbyopia Innovation Showcas..
AQ
01/26EYENOVIA : to Present at the Ophthalmology Innovation Summit (OIS) Presbyopia Innovation S..
BU
01/06EYENOVIA : to Participate in Presbyopia Panel Discussion at the LifeSci Partners 10th Annu..
AQ
2020EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020EYENOVIA : Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi T..
BU
2020EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020EYENOVIA : Announces First Patients Enrolled in Phase 3 Study of MicroLine for Presbyopia
BU
2020EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020EYENOVIA : Announces FDA Acceptance of IND for MicroLine for Presbyopia, Clearing Path to ..
BU
2020EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020EYENOVIA : Management's Discussion and Analysis of Financial Condition and Results of Oper..
AQ
2020EYENOVIA : Reports Third Quarter 2020 Financial Results
AQ
2020EYENOVIA, INC. : Results of Operations and Financial Condition, Financial Statements and E..
AQ
2020EYENOVIA : Reports Third Quarter 2020 Financial Results
AQ
2020Eyenovia Reports Third Quarter 2020 Financial Results
GL
2020EYENOVIA : to Report Third Quarter 2020 Results on Tuesday, November 10
AQ
2020Eyenovia to Report Third Quarter 2020 Results on Tuesday, November 10
GL
2020BAUSCH HEALTH : Licenses Eyenovia's Investigational Treatment for The Reduction of Pediatr..
AQ
2020BAUSCH HEALTH : Eyenovia to Host Investor Call to Discuss Recent Licensing Agreements Resu..
AQ
2020Eyenovia to Host Investor Call to Discuss Recent Licensing Agreements Resulting in Tota..
GL
2020EYENOVIA, INC. : Entry into a Material Definitive Agreement, Other Events, Financial State..
AQ
2020EYENOVIA : Bausch Health Licenses Eyenovia's Investigational Treatment For The Reduction O..
AQ
2020EYENOVIA : to Present Clinical Study Updates at the American Academy of Optometry Annual M..
BU
2020EYENOVIA : to Present at the 22nd Annual H.C. Wainwright Global Investment Conference
AQ
2020EYENOVIA : to Present at the 22nd Annual H.C. Wainwright Global Investment Conference
AQ
2020Eyenovia to Present at the 22nd Annual H.C. Wainwright Global Investment Conference
GL
2020EYENOVIA : Announces Underwriters Full Exercise of Over-Allotment Option in Public Offerin..
AQ
2020EYENOVIA : Announces Closing of Offering of Common Stock
AQ
2020Eyenovia, Inc. Announces Underwriters' Full Exercise of Over-Allotment Option in Public..
GL
2020EYENOVIA, INC. : Entry into a Material Definitive Agreement, Other Events, Financial State..
AQ
2020Eyenovia, Inc. Announces Closing of Offering of Common Stock
GL
1  2Next
Upcoming event on EYENOVIA, INC.
11/16/21